BOSTON - TransCode Therapeutics, Inc. (NASDAQ:RNAZ), a clinical stage company focused on immuno-oncology and RNA treatments for advanced cancer, announced Monday the appointment of Jack E. Stover to ...
BOSTON, Dec. 22, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA for the treatment of high risk and advanced cancer, ...
Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. Executive Editor David Carnoy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback